NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Epigallocatechin Gallate


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Investigators at Yonsei University publish new data on enzyme research
2009 NOV 16 ... procollagen-inducing effects of xanthorrhizol treatment were greater than those of epigallocatechin 3-O-gallate (EGCG), which is known to be a natural anti-aging agent," wrote H.I. Oh and ...
Subject: Enzyme Research
Price: $3.00
*
New caffeine therapy data have been reported by researchers at University of Copenhagen
2009 NOV 30 ... caffeine alone (150mg), or caffeine plus a catechin mixture (600 mg) enriched in either epigallocatechin-3-gallate (EGCG), epigallocatechin or a mix of catechins, in a randomised cross-over ...
Subject: Caffeine Therapy
Price: $3.00
*
New cardiology research reported from University of Alberta
2009 OCT 12 ... against a variety of human illnesses such as cancer, infection, and heart disease. (-)-Epigallocatechin gallate (EGCg), the prevalent flavonoid in green tea, modulates force generation in isolated ...
Subject: Cardiology
Price: $3.00
*
New findings from Kyoto University in the area of botany published
2009 OCT 27 ... Analysis of PA composition using the phloroglucinol method suggested that the amounts of epigallocatechin and its 3-O-gallate form were remarkably low in the PCNA type. In the PCNA type, the ...
Subject: Botany
Price: $3.00
*
New findings in hyperammonemia described by M. Li and co-researchers
2009 OCT 12 ... hyperinsulinemia/hyperammonemia forms of GDH are inhibited by the green tea polyphenols, epigallocatechin gallate and epicatechin gallate. This was followed by high throughput studies that identified ...
Subject: Hyperammonemia
Price: $3.00
*
New pancreatic cancer study findings have been reported by researchers at Ohio State University
2009 OCT 5 ... "(-)-Epigallocatechin-3-gallate [(-)-EGCG], the most abundant polyphenolic catechin in green tea, showed ...
Subject: Pancreatic Cancer
Price: $3.00
*
Reports from Hokkaido University describe recent advances in angiogenesis
2009 OCT 5 ... New investigation results, 'Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and ...
Subject: Angiogenesis
Price: $3.00
*
Reports summarize aging study results from W.S. Duan and co-researchers
2009 SEP 29 ... wrote W.S. Duan and colleagues. The researchers concluded: "Significantly, epigallocatechin gallate restored the Nrf2 activity." Duan and colleagues published their study in ...
Subject: Aging
Price: $3.00
*
Research from A. Miskon and co-researchers provides new data on gastroenterology
2009 NOV 1 ... porcine hepatocytes in monolayer and 3D culture systems was studied." "Epigallocatechin-3-gallate (EGCG), which has recently been found to have various bioactivities, was ...
Subject: Gastroenterology
Price: $3.00
*
Research from Fairfield University broadens understanding of antimicrobials
2009 NOV 30 ... containing a mixture of polyphenolic compounds. Cultures treated with 1.0 mu mol/L -(-)epigallocatechin-3-gallate (EGCG), the most abundant polyphenol, displayed a 75% reduction of viable ...
Subject: Antimicrobials
Price: $3.00
*
Research from National Taiwan University provide new insights into pancreas
2009 NOV 16 ... with higher mortality." "In this study, the tea polyphenol EGCG (epigallocatechin gallate) and the buckwheat flavonoid Rutin were investigated to attenuate the induced ...
Subject: Pancreas
Price: $3.00
*
Research on vascular endothelial growth factor discussed by scientists at Gifu University, Department of Internal Medicine
2009 OCT 5 ... Investigators publish new data in the report '(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation ...
Subject: Vascular Endothelial Growth Factor
Price: $3.00
*
Researchers at University of Texas target pharmaceuticals
2009 NOV 30 ... stilbene families found to possess metalloproteinase inhibitory activities include (-)-epigallocatechin gallate, (-)-epicatechin gallate and piceatannol, but their minimally active pharmacophores have ...
Subject: Pharmaceuticals
Price: $3.00
*
Researchers from Chungbuk National University describe findings in enzyme research
2009 NOV 1 ... have neuroprotective effects. In this study, we investigated the possible effects of (-)-epigallocatechin-3-gallate (EGCG) on memory dysfunction caused by A beta through the change of A ...
Subject: Enzyme Research
Price: $3.00
*
Scientists at Capital Medical University, Basic Medical College detail research in cervical cancer
2009 OCT 19 ... Scientists discuss in 'Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells' new findings in cervical cancer. According to ...
Subject: Cervical Cancer
Price: $3.00
*
Scientists at Fourth Military Medical University, Research Center report research in squamous cell carcinoma therapy
2009 OCT 19 ... carcinoma cells through telomerase repression,' new data in squamous cell carcinoma. "Epigallocatechin-3-gallate (EGCG), the major component of green tea polyphenol, has potent efficiency to ...
Subject: Squamous Cell Carcinoma Therapy
Price: $3.00
*
Studies from D.D. Chen et al in the area of cardiomegaly described
2009 NOV 2 ... Clinical and Experimental Pharmacology and Physiology, "It has been demonstrated that epigallocatechin-3-gallate (EGCG) inhibits cardiac hypertrophy through its antihypertensive and ...
Subject: Cardiomegaly
Price: $3.00
*
Studies in the area of ischemia reported from T.P. Zhang and co-researchers
2009 NOV 9 ... According to recent research from Beijing, People's Republic of China, "Epigallocatechin-3-gallate (EGCG), the major constituent of green tea, has been shown to promote ...
Subject: Ischemia
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login